Cytotoxicity of lipid-free apolipoprotein B

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 11, 2008, Pages 2594-2603

  Morita, Shin ya ^a   Deharu, Yuko ^b   Takata, Eriko ^b   Nakano, Minoru ^b   Handa, Tetsurou ^b  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Apolipoprotein B; Apoptosis; Atherosclerosis; Cytotoxicity; J774 macrophage; Plasma membrane

Indexed keywords

APOLIPOPROTEIN B; CALCEIN; CASPASE 3; FURA 2; LIPID; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE; SCAVENGER RECEPTOR A;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LIPID BILAYER; LIPID COMPOSITION; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANNEXIN A5; ANTIBODIES; APOLIPOPROTEINS B; CALCIUM SIGNALING; CASPASE 3; CELL DEATH; CELL LINE; CELL SHAPE; CELL SURVIVAL; CIRCULAR DICHROISM; ENZYME ACTIVATION; FLUORESCEINS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; INTRACELLULAR SPACE; L-LACTATE DEHYDROGENASE; MACROPHAGES; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SCAVENGER RECEPTORS, CLASS A;

EID: 54049105621     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.08.012     Document Type: Article

References (67)

1. Schwenke D.C., and Carew T.E. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 9 (1989) 895-907
2. Nievelstein P.F., Fogelman A.M., Mottino G., and Frank J.S. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler. Thromb. 11 (1991) 1795-1805
3. Kockx M.M., De Meyer G.R., Muhring J., Jacob W., Bult H., and Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97 (1998) 2307-2315
4. Napoli C. Oxidation of LDL, atherogenesis, and apoptosis. Ann. N. Y. Acad. Sci. 1010 (2003) 698-709
5. Mallat Z., and Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 130 (2000) 947-962
6. Kockx M.M., and Knaapen M.W. The role of apoptosis in vascular disease. J. Pathol. 190 (2000) 267-280
7. McCarthy N.J., and Bennett M.R. The regulation of vascular smooth muscle cell apoptosis. Cardiovasc. Res. 45 (2000) 747-755
8. Rossig L., Dimmeler S., and Zeiher A.M. Apoptosis in the vascular wall and atherosclerosis. Basic Res. Cardiol. 96 (2001) 11-22
9. Liu J., Thewke D.P., Su Y.R., Linton M.F., Fazio S., and Sinensky M.S. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 174-179
10. Arai S., Shelton J.M., Chen M., Bradley M.N., Castrillo A., Bookout A.L., Mak P.A., Edwards P.A., Mangelsdorf D.J., Tontonoz P., and Miyazaki T. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab. 1 (2005) 201-213
11. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2255-2264
12. Wyler von Ballmoos M., Dubler D., Mirlacher M., Cathomas G., Muser J., and Biedermann B.C. Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 359-364
13. Esser V., Limbird L.E., Brown M.S., Goldstein J.L., and Russell D.W. Mutational analysis of the ligand binding domain of the low density lipoprotein receptor. J. Biol. Chem. 263 (1988) 13282-13290
14. Galeano N.F., Al-Haideri M., Keyserman F., Rumsey S.C., and Deckelbaum R.J. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J. Lipid Res. 39 (1998) 1263-1273
15. Rizzo M., and Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. Qjm 99 (2006) 1-14
16. Ayyobi A.F., McGladdery S.H., McNeely M.J., Austin M.A., Motulsky A.G., and Brunzell J.D. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1289-1294
17. Johs A., Hammel M., Waldner I., May R.P., Laggner P., and Prassl R. Modular structure of solubilized human apolipoprotein B-100. Low resolution model revealed by small angle neutron scattering. J. Biol. Chem. 281 (2006) 19732-19739
18. Steele Jr. J.C., and Reynolds J.A. Characterization of the apolipoprotein B polypeptide of human plasma low density lipoprotein in detergent and denaturation solutions. J. Biol. Chem. 254 (1979) 1633-1638
19. Walsh M.T., and Atkinson D. Solubilization of low-density lipoprotein with sodium deoxycholate and recombination of apoprotein B with dimyristoylphosphatidylcholine. Biochemistry 22 (1983) 3170-3178
20. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
21. Jayaraman S., Gantz D., and Gursky O. Structural basis for thermal stability of human low-density lipoprotein. Biochemistry 44 (2005) 3965-3971
22. Parasassi T., Bittolo-Bon G., Brunelli R., Cazzolato G., Krasnowska E.K., Mei G., Sevanian A., and Ursini F. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-). Free Radic. Biol. Med. 31 (2001) 82-89
23. Morita S.Y., Kawabe M., Nakano M., and Handa T. Pluronic L81 affects the lipid particle sizes and apolipoprotein B conformation. Chem. Phys. Lipids 126 (2003) 39-48
24. Brunelli R., Mei G., Krasnowska E.K., Pierucci F., Zichella L., Ursini F., and Parasassi T. Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation. Biochemistry 39 (2000) 13897-13903
25. Jayaraman S., Gantz D.L., and Gursky O. Effects of oxidation on the structure and stability of human low-density lipoprotein. Biochemistry 46 (2007) 5790-5797
26. Parasassi T., De Spirito M., Mei G., Brunelli R., Greco G., Lenzi L., Maulucci G., Nicolai E., Papi M., Arcovito G., Tosatto S.C., and Ursini F. Low density lipoprotein misfolding and amyloidogenesis. FASEB J. 22 (2008) 2350-2356
27. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110 (2002) 905-911
28. Mahley R.W., and Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40 (1999) 1-16
29. Goldstein J.L., Basu S.K., Brunschede G.Y., and Brown M.S. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell 7 (1976) 85-95
30. Fuki I.V., Kuhn K.M., Lomazov I.R., Rothman V.L., Tuszynski G.P., Iozzo R.V., Swenson T.L., Fisher E.A., and Williams K.J. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100 (1997) 1611-1622
31. Al-Haideri M., Goldberg I.J., Galeano N.F., Gleeson A., Vogel T., Gorecki M., Sturley S.L., and Deckelbaum R.J. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry 36 (1997) 12766-12772
32. Fuki I.V., Blanchard N., Jin W., Marchadier D.H., Millar J.S., Glick J.M., and Rader D.J. Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway. J. Biol. Chem. 278 (2003) 34331-34338
33. Sakr S.W., Eddy R.J., Barth H., Wang F., Greenberg S., Maxfield F.R., and Tabas I. The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin cytoskeleton, Rho family GTPases, and myosin ATPase activity. J. Biol. Chem. 276 (2001) 37649-37658
34. Morita S.Y., Kawabe M., Sakurai A., Okuhira K., Vertut-Doi A., Nakano M., and Handa T. Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages. J. Biol. Chem. 279 (2004) 24355-24361
35. Chin J.H., Tse F.W., Harris K., and Jhamandas J.H. Beta-amyloid enhances intracellular calcium rises mediated by repeated activation of intracellular calcium stores and nicotinic receptors in acutely dissociated rat basal forebrain neurons. Brain Cell. Biol. 35 (2006) 173-186
36. Gantz D.L., Walsh M.T., and Small D.M. Morphology of sodium deoxycholate-solubilized apolipoprotein B-100 using negative stain and vitreous ice electron microscopy. J. Lipid Res. 41 (2000) 1464-1472
37. Walsh M.T., and Atkinson D. Physical properties of apoprotein B in mixed micelles with sodium deoxycholate and in a vesicle with dimyristoyl phosphatidylcholine. J. Lipid Res. 27 (1986) 316-325
38. Walsh M.T., and Atkinson D. Calorimetric and spectroscopic investigation of the unfolding of human apolipoprotein B. J. Lipid Res. 31 (1990) 1051-1062
39. Piha M., Lindstedt L., and Kovanen P.T. Fusion of proteolyzed low-density lipoprotein in the fluid phase: a novel mechanism generating atherogenic lipoprotein particles. Biochemistry 34 (1995) 10120-10129
40. Schissel S.L., Tweedie-Hardman J., Rapp J.H., Graham G., Williams K.J., and Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98 (1996) 1455-1464
41. Schissel S.L., Jiang X., Tweedie-Hardman J., Jeong T., Camejo E.H., Najib J., Rapp J.H., Williams K.J., and Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 273 (1998) 2738-2746
42. Hurt-Camejo E., Camejo G., and Sartipy P. Phospholipase A2 and small, dense low-density lipoprotein. Curr. Opin. Lipidol. 11 (2000) 465-471
43. Asatryan L., Hamilton R.T., Isas J.M., Hwang J., Kayed R., and Sevanian A. LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein. J. Lipid Res. 46 (2005) 115-122
44. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol. Pharm. Bull. 26 (2003) 1-9
45. Ursini F., Davies K.J., Maiorino M., Parasassi T., and Sevanian A. Atherosclerosis: another protein misfolding disease?. Trends Mol. Med. 8 (2002) 370-374
46. Brouillette C.G., and Anantharamaiah G.M. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta 1256 (1995) 103-129
47. Law A., and Scott J. A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor. J. Lipid Res. 31 (1990) 1109-1120
48. Weisgraber K.H., and Rall Jr. S.C. Human apolipoprotein B-100 heparin-binding sites. J. Biol. Chem. 262 (1987) 11097-11103
49. Olsson U., Camejo G., Hurt-Camejo E., Elfsber K., Wiklund O., and Bondjers G. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 149-155
50. Steinbrecher U.P. Receptors for oxidized low density lipoprotein. Biochim. Biophys. Acta 1436 (1999) 279-298
51. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., Rhee J.S., Silverstein R., Hoff H.F., and Freeman M.W. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 (2002) 49982-49988
52. Naito M., Suzuki H., Mori T., Matsumoto A., Kodama T., and Takahashi K. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am. J. Pathol. 141 (1992) 591-599
53. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (2003) 552-565
54. Segrest J.P., Jones M.K., De Loof H., and Dashti N. Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid Res. 42 (2001) 1346-1367
55. Wang L., and Small D.M. Interfacial properties of amphipathic beta strand consensus peptides of apolipoprotein B at oil/water interfaces. J. Lipid Res. 45 (2004) 1704-1715
56. Wang L., Walsh M.T., and Small D.M. Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6871-6876
57. Rava P., Ojakian G.K., Shelness G.S., and Hussain M.M. Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins. J. Biol. Chem. 281 (2006) 11019-11027
58. Stewart C.R., Tseng A.A., Mok Y.F., Staples M.K., Schiesser C.H., Lawrence L.J., Varghese J.N., Moore K.J., and Howlett G.J. Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages. Biochemistry 44 (2005) 9108-9116
59. Higuchi K., Kitagawa K., Naiki H., Hanada K., Hosokawa M., and Takeda T. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem. J. 279 Pt 2 (1991) 427-433
60. Westermark P., Mucchiano G., Marthin T., Johnson K.H., and Sletten K. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am. J. Pathol. 147 (1995) 1186-1192
61. Wisniewski T., Lalowski M., Golabek A., Vogel T., and Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis?. Lancet 345 (1995) 956-958
62. Hatters D.M., MacPhee C.E., Lawrence L.J., Sawyer W.H., and Howlett G.J. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry 39 (2000) 8276-8283
63. Mucchiano G.I., Jonasson L., Haggqvist B., Einarsson E., and Westermark P. Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol. Am. J. Clin. Pathol. 115 (2001) 298-303
64. Mucchiano G.I., Haggqvist B., Sletten K., and Westermark P. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J. Pathol. 193 (2001) 270-275
65. Bergstrom J., Murphy C., Eulitz M., Weiss D.T., Westermark G.T., Solomon A., and Westermark P. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem. Biophys. Res. Commun. 285 (2001) 903-908
66. Pham C.L., Hatters D.M., Lawrence L.J., and Howlett G.J. Cross-linking and amyloid formation by N- and C-terminal cysteine derivatives of human apolipoprotein C-II. Biochemistry 41 (2002) 14313-14322
67. Medeiros L.A., Khan T., El Khoury J.B., Pham C.L., Hatters D.M., Howlett G.J., Lopez R., O'Brien K.D., and Moore K.J. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279 (2004) 10643-10648